e-Drug3D

1147

MOLINDONE


INN
MOLINDONE

cas 7416-34-4
CLASS

NERVOUS SYSTEM
ANTIPSYCHOTIC
MANAGEMENT OF SCHIZOPHRENIA
DOPAMINE RECEPTOR ANTAGONIST

ROUTE (list)

ORAL

ATC code

N05AE02

PK parameters

Tmax 1.5 HOUR
t1/2 2 HOUR

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET D(2) DOPAMINE RECEPTOR

DrugCentral

D(2) dopamine receptor UNIPROT P14416 DRD2

5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A

Download SDF file 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one

Formula:
C16H24N2O2

Calculated chemical properties:

MW 276.37
NB_atoms 20
XLogP 1.96
PSA 45.341
NB_HD 1
NB_HA 4
fsp3 0.69
Lipinski(0=no;1=yes) 1

FDA
NDA 017111 (label) INN (MOLINDONE HYDROCHLORIDE) MOBAN (CHARTWELL RX) APPROVAL= AP YEAR= 1974 DISCONTINUED
NDA 017938 (pdf not found) INN (MOLINDONE HYDROCHLORIDE) MOBAN (ENDO PHARMS) APPROVAL= AP YEAR= 1979 DISCONTINUED
NDA 090453 (pdf not found) INN (MOLINDONE HYDROCHLORIDE) MOLINDONE HYDROCHLORIDE (EPIC PHARMA LLC) APPROVAL= AP YEAR= 2015

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL